English
Cell fabbrikijintużaw prinċipalment għall-kultura taċ-ċelluli fuq skala kbira. Iċ-ċelloli għandhom rekwiżiti għoljin fuq l-ambjent, bħal temperatura, umdità, pressjoni osmotika, valur tal-pH, eċċ. Għalhekk, dan it-tip ta’ cell konsumabbli għandu wkoll rekwiżiti għoljin fuq materja prima.
L-ewwel hija t-trasparenza. Fil-proċess tal-kultura taċ-ċelluli, huwa meħtieġ li taqbad l-istat tat-tkabbir taċ-ċelloli fi kwalunkwe ħin, u tagħmel aġġustamenti korrispondenti skont il-proliferazzjoni taċ-ċelluli. Għalhekk, il-materja prima tal-fabbrika taċ-ċelluli għandha tissodisfa r-rekwiżiti tat-trasparenza, sabiex ikun konvenjenti għar-riċerkaturi li josservaw it-tkabbir taċ-ċelloli.
It-tieni hija l-kompatibilità tal-materjali. Il-materja prima ta 'dan il-konsumabbli ġeneralment tissodisfa r-rekwiżiti tal-materjali tal-polimer mediku USP Klassi VI. Materjali polimeri mediċi jirreferu għal materjali polimeri użati għall-manifattura ta 'organi interni umani, organi esterni, forom ta' dożaġġ farmaċewtiċi u apparat mediku, u s-sorsi tagħhom jinkludu materjali bijopolimeri naturali u materjali bijopolimeri sintetiċi. Hemm 6 livelli ta 'USP Klassi I-USP Klassi VI fit-test tal-klassifikazzjoni tal-plastik tal-Istati Uniti, u plastik ikklassifikat bħala s-sitt livell tal-plastiks mediċi tal-Istati Uniti jfisser li ġie stabbilit test komprensiv ħafna u rigoruż. L-oġġetti tat-test tiegħu jinkludu test tat-tossiċità sistemika (ġrieden), test ta 'reazzjoni intradermali (fenek), u test ta' impjantazzjoni (fenek). Livell 6 huwa l-istandard tad-deheb għal kull tip ta 'materja prima ta' grad mediku u għażla ta 'kwalità għolja ħafna għall-manifatturi ta' apparat mediku. dan il-grad huma ta 'purità għolja, li jistgħu jiżguraw it-trasparenza tal-prodott lest u huwa aktar li jwassal għall-assorbiment ta' ċelluli aderenti.
fabbrika taċ-ċellulicell factory chooses USP grade VI medical polymer materials is that the raw materials of this grade are of high purity, which can ensure the transparency of the finished product and is more conducive to the adsorption of adherent cells.
The FAI climbed 5.9 percent year-on-year in the first 11 months of 2018, quickening from the 5.7-percent growth in Jan-Oct, the National Bureau of Statistics (NBS) said Friday in an online statement.
The key indicator of investment, dubbed a major growth driver, hit the bottom in August and has since started to rebound steadily.
In the face of emerging economic challenges home and abroad, China has stepped up efforts to stabilize investment, in particular rolling out measures to motivate private investors and channel funds into infrastructure.
Friday's data showed private investment, accounting for more than 60 percent of the total FAI, expanded by a brisk 8.7 percent.
NBS spokesperson Mao Shengyong said funds into weak economic links registered rapid increases as investment in environmental protection and agriculture jumped 42 percent and 12.5 percent respectively, much faster than the average.
In breakdown, investment in high-tech and equipment manufacturing remained vigorous with 16.1-percent and 11.6-percent increases respectively in the first 11 months. Infrastructure investment gained 3.7 percent, staying flat. Investment in property development rose 9.7 percent, also unchanged.